Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-3-4
pubmed:abstractText
This study examined whether d-cycloserine, a partial agonist at the N-methyl-D-aspartate (NMDA) glutamatergic receptor, enhances the efficacy of behavior therapy for obsessive-compulsive disorder (OCD).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-953X
pubmed:author
pubmed:issnType
Print
pubmed:volume
165
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
335-41; quiz 409
pubmed:dateRevised
2008-9-4
pubmed:meshHeading
pubmed-meshheading:18245177-Adult, pubmed-meshheading:18245177-Animals, pubmed-meshheading:18245177-Behavior Therapy, pubmed-meshheading:18245177-Combined Modality Therapy, pubmed-meshheading:18245177-Cycloserine, pubmed-meshheading:18245177-Diagnostic and Statistical Manual of Mental Disorders, pubmed-meshheading:18245177-Double-Blind Method, pubmed-meshheading:18245177-Female, pubmed-meshheading:18245177-Follow-Up Studies, pubmed-meshheading:18245177-Humans, pubmed-meshheading:18245177-Implosive Therapy, pubmed-meshheading:18245177-Obsessive-Compulsive Disorder, pubmed-meshheading:18245177-Placebos, pubmed-meshheading:18245177-Psychiatric Status Rating Scales, pubmed-meshheading:18245177-Rats, pubmed-meshheading:18245177-Receptors, N-Methyl-D-Aspartate, pubmed-meshheading:18245177-Recurrence, pubmed-meshheading:18245177-Severity of Illness Index, pubmed-meshheading:18245177-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
pubmed:affiliation
Obsessive-Compulsive Disorder Clinic, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA. wilhelm@psych.mgh.harvard.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Case Reports, Research Support, Non-U.S. Gov't